An Assessment of Early Response to Targeted Therapy via Molecular Imaging: A Pilot Study of 3′-deoxy-3′[(18)F]-Fluorothymidine Positron Emission Tomography (18)F-FLT PET/CT in Prostate Adenocarcinoma

Fluorothymidine is a thymidine analog labeled with fluorine-18 fluorothymidine for positron emission tomography ((18)F-FLT-PET) imaging. Thymidine is a nucleic acid that is used to build DNA. Fluorine-18 fluorothymidine ((18)F-FLT) utilizes the same metabolic pathway as does thymidine but has a very...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Diagnostics (Basel)
Päätekijät: Kairemo, Kalevi, Ravizzini, Gregory C., Macapinlac, Homer A., Subbiah, Vivek
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2017
Aiheet:
Brief Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5489940/
https://ncbi.nlm.nih.gov/pubmed/28375169
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics7020020
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia